Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between Body Fat composition and serum branched chain amino acids in patients with visceral obesity.

BMC endocrine disorders·2026
Same author

Profound immune suppression and exhaustion characterize refractory mycoplasma pneumoniae pneumonia in children.

Frontiers in immunology·2026
Same author

Fibroblast Mitochondrial Ca2+ Overload Drives Skin Fibrosis via mtDNA Leakage and cGAS-STING Activation in Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Development of nano-micro composite Xiaochaihu decoction granules for enhanced antipyretic and anti-inflammatory efficacy.

Analytical biochemistry·2026
Same author

Leveraging Framework Dynamics: Solvent-Triggered Breathing in MOFs for Enhanced CO<sub>2</sub> Photoreduction.

Inorganic chemistry·2026
Same author

Exploring chronic pain: demographic and social determinants of health insights in Maine.

Frontiers in pain research (Lausanne, Switzerland)·2026

Related Experiment Video

Updated: May 10, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

Progress in Brucella vaccine development.

Xinghong Yang1, Jerod A Skyberg, Ling Cao

  • 1Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA.

Frontiers in Biology
|June 5, 2013
PubMed
Summary

Brucellosis vaccines are crucial for both animal and human health. This review highlights promising new live and subunit vaccine candidates for brucellosis, offering improved safety and efficacy.

Keywords:
Brucellabrucellosislivestock vaccineszoonosis

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Experiment Videos

Last Updated: May 10, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Area of Science:

  • Veterinary Medicine
  • Infectious Diseases
  • Immunology

Background:

  • Brucella spp. are zoonotic pathogens causing significant animal and human disease, including abortions and flu-like symptoms.
  • Current antibiotic treatments for human brucellosis are lengthy and not always fully effective.
  • Existing live Brucella vaccines for livestock vary in performance based on host, dose, and administration route.

Purpose of the Study:

  • To review the current progress in brucellosis vaccine development.
  • To provide an overview of candidate vaccines for both animal and human applications.
  • To highlight novel vaccine strategies with enhanced safety and efficacy.

Main Methods:

  • Literature review of brucellosis vaccine research.
  • Analysis of existing licensed live Brucella vaccines for livestock.
  • Evaluation of newly engineered live and subunit vaccine candidates.

Main Results:

  • Newly engineered live vaccines offer high protection with low residual virulence and potential human applications.
  • Subunit vaccines demonstrate significant promise for livestock and human use due to enhanced safety and efficacy in animal models.
  • Vaccine performance is influenced by host species, dose, and immunization route.

Conclusions:

  • Advanced live and subunit vaccines are emerging as promising alternatives to current brucellosis control strategies.
  • These novel vaccines hold potential for broader applications in both veterinary and human medicine.
  • Continued research into Brucella vaccine development is essential for combating this zoonotic disease.